mTOR Inhibitor Immunosuppressant class drugs
4 results
Everolimus (everolimus)
(Everolimus)Ascend Laboratories, LLC
Usage: Everolimus tablets are indicated for the prevention of organ rejection in adult kidney transplant patients at low to moderate immunologic risk and in liver transplant patients, administered with specific immunosuppressants. Therapeutic drug monitoring is recommended. Safety has not been established for high-risk kidney recipients or in pediatric patients.
Fyarro (sirolimus)
(Sirolimus)Aadi Bioscience
Usage: FYARRO™ is indicated for treating adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).
Sirolimus (sirolimus)
(Sirolimus)Ascend Laboratories, LLC
Usage: Sirolimus is indicated for the prophylaxis of organ rejection in renal transplant patients aged 13 and older, particularly in high-risk groups, and for the treatment of lymphangioleiomyomatosis (LAM). Its use involves specific combinations with cyclosporine and corticosteroids based on immunologic risk levels.
Sirolimus (sirolimus)
(sirolimus)Zydus Lifesciences Limited